These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29325270)

  • 41. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
    Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma prealbumin in women with epithelial ovarian carcinoma.
    Mählck CG; Grankvist K
    Gynecol Obstet Invest; 1994; 37(2):135-40. PubMed ID: 8150370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines.
    Zhou J; Ye F; Chen H; Lv W; Gan N
    J Int Med Res; 2007; 35(3):290-300. PubMed ID: 17593856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma.
    Terada T
    Arch Gynecol Obstet; 2011 Jun; 283(6):1403-6. PubMed ID: 20652287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
    Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
    Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of evidence for aromatase expression in human ovarian epithelial carcinoma.
    Imai A; Ohno T; Takahashi K; Furui T; Tamaya T
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():65-71. PubMed ID: 8154854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating tumor-associated antigen detected by the murine monoclonal antibody CF511 in human epithelial ovarian carcinoma.
    Murae M; Ohkawa K; Kimura E
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1841-8. PubMed ID: 2687410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and treatment of epithelial ovarian cancer.
    Schwartz PE
    Minerva Ginecol; 2003 Aug; 55(4):315-26. PubMed ID: 14581856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research development of circulating tumor cell in ovarian epithelial carcinoma].
    Zhonghua Fu Chan Ke Za Zhi; 2017 Dec; 52(12):853-856. PubMed ID: 29325270
    [No Abstract]   [Full Text] [Related]  

  • 57. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.